Related Experiment Video
Updated: Jul 6, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Meeting report: cGMP matters
Barbara Kemp-Harper1, Robert Feil
1Department of Pharmacology and Centre for Vascular Health, Monash University, Clayton, Victoria, Australia. Barbara.Kemp@med.monash.edu.au
Abstract:
The second messenger cyclic guanosine 3',5'-monophosphate (cGMP) controls many cellular functions ranging from growth to contractility. Generated from guanylyl cyclases in response to natriuretic peptides or nitric oxide, cGMP transduces its effects through a number of cGMP effectors, including cGMP-regulated phosphodiesterases and protein kinases. Drugs that modulate cGMP levels are emerging as promising therapies, particularly for cardiovascular disorders. This report summarizes new data on the molecular mechanisms, (patho)physiological relevance, and therapeutic potential of the cGMP signaling system that were presented at the 3rd cGMP meeting held in June 2007 in Dresden, Germany.
More Related Videos
Related Concept Videos
Good Manufacturing Practices
FDA Approved Drugs: Changes to Approved Drugs
Types of Reports I: Hand-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Hazard Analysis and Critical Control Points (HACCP)

